Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in Endogenous Cushing's Syndrome (SEISMIC)
NCT00569582Phase 3Completed
- Sponsor
- Corcept Therapeutics
- Start
- Dec 2007
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone in Cushing's syndrome, sponsored by Corcept Therapeutics. Started Dec 2007; status: completed.
02
Drugs
mifepristone
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT00569582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569582.